<VariationArchive VariationID="280322" VariationName="NM_213599.3(ANO5):c.304_308del (p.Lys102fs)" VariationType="Deletion" Accession="VCV000280322" Version="31" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-17" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="264605" VariationID="280322">
      <GeneList>
        <Gene Symbol="ANO5" FullName="anoctamin 5" GeneID="203859" HGNC_ID="HGNC:27337" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22192473" stop="22283357" display_start="22192473" display_stop="22283357" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22214721" stop="22304912" display_start="22214721" display_stop="22304912" Strand="+" />
          </Location>
          <OMIM>608662</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_213599.3(ANO5):c.304_308del (p.Lys102fs)</Name>
      <CanonicalSPDI>NC_000011.10:22225988:AAGAAAAGA:AAGA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22225989" stop="22225993" display_start="22225989" display_stop="22225993" variantLength="5" positionVCF="22225988" referenceAlleleVCF="GAAGAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22247535" stop="22247539" display_start="22247535" display_stop="22247539" variantLength="5" positionVCF="22247534" referenceAlleleVCF="GAAGAA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>K102fs</ProteinChange>
      <ProteinChange>K101fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.22225993_22225997del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.22225993_22225997del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.22247539_22247543del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.22247539_22247543del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015844.1" sequenceAccession="NG_015844" sequenceVersion="1" change="g.37818_37822del">
            <Expression>NG_015844.1:g.37818_37822del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142649.2" sequenceAccession="NM_001142649" sequenceVersion="2" change="c.301_305del">
            <Expression>NM_001142649.2:c.301_305del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001136121.1" sequenceAccession="NP_001136121" sequenceVersion="1" change="p.Lys101fs">
            <Expression>NP_001136121.1:p.Lys101fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_213599.3" sequenceAccession="NM_213599" sequenceVersion="3" change="c.304_308del" MANESelect="true">
            <Expression>NM_213599.3:c.304_308del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_998764.1" sequenceAccession="NP_998764" sequenceVersion="1" change="p.Lys102fs">
            <Expression>NP_998764.1:p.Lys102fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_213599.3" sequenceAccession="NM_213599" sequenceVersion="3" change="c.304_308delAAAGA" MANESelect="true">
            <Expression>NM_213599.3:c.304_308delAAAGA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_213599.2" sequenceAccession="NM_213599" sequenceVersion="2" change="c.304_308delAAAGA">
            <Expression>NM_213599.2:c.304_308delAAAGA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_868" sequenceAccession="LRG_868">
            <Expression>LRG_868:g.37818_37822del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_868t1" sequenceAccession="LRG_868t1">
            <Expression>LRG_868t1:c.304_308del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_868p1" sequenceAccession="LRG_868p1" change="p.Lys102fs">
            <Expression>LRG_868p1:p.Lys102fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA5922882" DB="ClinGen" />
        <XRef Type="rs" ID="776859202" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_213599.3(ANO5):c.304_308del (p.Lys102fs) AND not provided" Accession="RCV000364776" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2016-09-19" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.304_308del (p.Lys102fs) AND multiple conditions" Accession="RCV000509433" Version="2">
        <ClassifiedConditionList TraitSetID="9870">
          <ClassifiedCondition DB="MedGen" ID="C1969785">Autosomal recessive limb-girdle muscular dystrophy type 2L</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833736">Gnathodiaphyseal dysplasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2750076">Miyoshi muscular dystrophy 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.304_308del (p.Lys102fs) AND multiple conditions" Accession="RCV001067775" Version="5">
        <ClassifiedConditionList TraitSetID="39863">
          <ClassifiedCondition DB="MedGen" ID="C1969785">Autosomal recessive limb-girdle muscular dystrophy type 2L</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833736">Gnathodiaphyseal dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.304_308del (p.Lys102fs) AND Abnormality of the musculature" Accession="RCV001814138" Version="1">
        <ClassifiedConditionList TraitSetID="24200">
          <ClassifiedCondition DB="MedGen" ID="C4021745">Abnormality of the musculature</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-20" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21186264</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23606453</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25891276</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27862037</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30919934</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ANO5</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="9870" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1391" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                <XRef ID="MONDO:0008151" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GDD</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8698" />
                <XRef ID="8698" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53697" DB="Orphanet" />
              <XRef ID="C1833736" DB="MedGen" />
              <XRef ID="MONDO:0008151" DB="MONDO" />
              <XRef Type="MIM" ID="166260" DB="OMIM" />
            </Trait>
            <Trait ID="6803" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Miyoshi myopathy 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 3</ElementValue>
                <XRef ID="Miyoshi+muscular+dystrophy+3/8905" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013222" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD3</ElementValue>
                <XRef Type="MIM" ID="613319" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17653" />
                <XRef ID="17653" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="399096" DB="Orphanet" />
              <XRef ID="C2750076" DB="MedGen" />
              <XRef ID="MONDO:0013222" DB="MONDO" />
              <XRef Type="MIM" ID="613319" DB="OMIM" />
            </Trait>
            <Trait ID="2991" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                <XRef ID="MONDO:0012652" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12536" />
                <XRef ID="12536" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="206549" DB="Orphanet" />
              <XRef ID="C1969785" DB="MedGen" />
              <XRef ID="MONDO:0012652" DB="MONDO" />
              <XRef Type="MIM" ID="611307" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="39863" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1391" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                <XRef ID="MONDO:0008151" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GDD</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8698" />
                <XRef ID="8698" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53697" DB="Orphanet" />
              <XRef ID="C1833736" DB="MedGen" />
              <XRef ID="MONDO:0008151" DB="MONDO" />
              <XRef Type="MIM" ID="166260" DB="OMIM" />
            </Trait>
            <Trait ID="2991" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                <XRef ID="MONDO:0012652" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12536" />
                <XRef ID="12536" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="206549" DB="Orphanet" />
              <XRef ID="C1969785" DB="MedGen" />
              <XRef ID="MONDO:0012652" DB="MONDO" />
              <XRef Type="MIM" ID="611307" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="24200" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="23481" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Abnormality of the musculature</ElementValue>
                <XRef ID="HP:0003011" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C4021745" DB="MedGen" />
              <XRef Type="primary" ID="HP:0003011" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003197" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003708" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="645396" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="29210_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000331883" DateUpdated="2018-12-15" DateCreated="2016-12-06" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-09-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25891276</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="-" referenceAllele="AAAGA" start="22247539" stop="22247543" variantLength="5" />
            <GeneLocation>NM_213599.2:Ex6</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD155965" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ANO5</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="643576" SubmissionDate="2019-01-29" DateLastUpdated="2018-12-15" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDX:898259|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000330226" DateUpdated="2018-12-15" DateCreated="2016-12-06" Type="SCV" Version="6" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-02-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.304_308delAAAGA pathogenic variant in the ANO5 gene has been reported previously in the compound heterozygous state along with another ANO5 pathogenic variant in an individual with mild calf hypertrophy, elevated CK, and central nuclei and increased fiber size identified histologically (Savarese et al., 2015). The deletion causes a frameshift starting with codon Lysine 102, changes this amino acid to a Valine residue and creates a premature Stop codon at position 2 of the new reading frame, denoted p.Lys102ValfsX2. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Therefore, c.304_308delAAAGA is considered a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.304_308delAAAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3453226" SubmissionDate="2021-09-09" DateLastUpdated="2022-01-22" DateCreated="2022-01-22">
        <ClinVarSubmissionID localKey="9802919|HPO:HP:0003011" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001755343" DateUpdated="2022-01-22" DateCreated="2022-01-22" Type="SCV" Version="1" SubmitterName="Kariminejad - Najmabadi Pathology &amp; Genetics Center" OrgID="506221" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.3:c.304_308delAAAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0003011" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10350875</SubmissionName>
          <SubmissionName>SUB9989790</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2398473" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="1314520|MedGen:C1969785;C1833736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001232854" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23606453</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25891276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30919934</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25891276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27862037</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys102Valfs*2) in the ANO5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ANO5 are known to be pathogenic (PMID: 21186264, 23606453, 25891276, 30919934). This variant is present in population databases (rs776859202, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with autosomal recessive limb-girdle muscular dystrophy (PMID: 25891276, 27862037). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 280322). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.22247535_22247539del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1969785" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1833736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1174306" SubmissionDate="2017-08-22" DateLastUpdated="2024-06-17" DateCreated="2017-10-16">
        <ClinVarSubmissionID localKey="genomeconnect_14826_622" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000607143" DateUpdated="2024-06-17" DateCreated="2017-10-16" Type="SCV" Version="2" SubmitterName="GenomeConnect, ClinGen" OrgID="506185" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">40</Age>
              <Age Type="maximum" age_unit="years">49</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>phenotyping only</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Gene Panel Sequencing</Attribute>
              </MethodAttribute>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2015-04-23" integerValue="500060">Eurofins Ntd Llc (ga)</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2015-05-27" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Hyperthyroidism</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000836" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the parathyroid physiology</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0011767" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Myopia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000545" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Short attention span</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000736" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of muscle physiology</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0011804" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">EMG abnormality</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0003457" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the musculature of the limbs</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0009127" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the musculature of the thorax</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0009131" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the musculature of the pelvis</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001469" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Decreased pulmonary function</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0005952" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.304_308delAAAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166260" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611307" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613319" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GenomeConnect_hg19_81817</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the parathyroid physiology" MappingRef="Preferred">
        <MedGen CUI="C4023198" Name="Abnormality of the parathyroid physiology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3453226" TraitType="Disease" MappingType="XRef" MappingValue="HP:0003011" MappingRef="HP">
        <MedGen CUI="C4021745" Name="Abnormality of the musculature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Disease" MappingType="XRef" MappingValue="613319" MappingRef="OMIM">
        <MedGen CUI="C2750076" Name="Miyoshi muscular dystrophy 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Finding" MappingType="Name" MappingValue="EMG abnormality" MappingRef="Preferred">
        <MedGen CUI="C0476403" Name="EMG abnormality" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="643576" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Finding" MappingType="Name" MappingValue="Myopia" MappingRef="Preferred">
        <MedGen CUI="C0027092" Name="Myopia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the musculature of the thorax" MappingRef="Preferred">
        <MedGen CUI="C4024580" Name="Abnormality of the musculature of the thorax" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the musculature of the limbs" MappingRef="Preferred">
        <MedGen CUI="C4024582" Name="Abnormality of the musculature of the limbs" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="645396" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Finding" MappingType="Name" MappingValue="Short attention span" MappingRef="Preferred">
        <MedGen CUI="C0262630" Name="Short attention span" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Disease" MappingType="XRef" MappingValue="611307" MappingRef="OMIM">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Finding" MappingType="Name" MappingValue="Hyperthyroidism" MappingRef="Preferred">
        <MedGen CUI="C0020550" Name="Hyperthyroidism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Disease" MappingType="XRef" MappingValue="166260" MappingRef="OMIM">
        <MedGen CUI="C1833736" Name="Gnathodiaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of muscle physiology" MappingRef="Preferred">
        <MedGen CUI="C4023182" Name="Abnormal muscle physiology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2398473" TraitType="Disease" MappingType="XRef" MappingValue="C1969785" MappingRef="MedGen">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2398473" TraitType="Disease" MappingType="XRef" MappingValue="C1833736" MappingRef="MedGen">
        <MedGen CUI="C1833736" Name="Gnathodiaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174306" TraitType="Finding" MappingType="Name" MappingValue="Decreased pulmonary function" MappingRef="Preferred">
        <MedGen CUI="C0235063" Name="Decreased pulmonary function" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

